Nectin-4 as Blood-Based Biomarker Enables Detection of Early Ovarian Cancer Stages

Nectin-4 as Blood-Based Biomarker Enables Detection of Early Ovarian Cancer Stages

Ovarian cancer is the third most common gynecological malignancy and has the highest mortality rate. Owing to unspecific symptoms, ovarian cancer is not detected until an advanced stage in about two-thirds of cases. Therefore, it is crucial to establish reliable biomarkers for the early stages to im...

Full description

Bibliographic Details
Main Authors: Christoph Rogmans, Julia Feuerborn, Leonie Treeck, Nils Tribian, Inken Flörkemeier, Norbert Arnold, Jörg Paul Weimer, Nicolai Maass, Peer Jansen, Wolfgang Lieb, Astrid Dempfle, Dirk O. Bauerschlag, Nina Hedemann
Format: Article
Language:English
Published: MDPI AG 2022-11-01
Series:Cancers
Subjects:
ovarian cancer
Nectin-4
HB-EGF
Amphiregulin
tumor marker
early detection
Online Access:https://www.mdpi.com/2072-6694/14/23/5867

Internet

https://www.mdpi.com/2072-6694/14/23/5867

Similar Items